Skip to content

Chinese Cohort Study of Coronary Heart Disease

Cross-Sectional Investigation of Secondary Prevention on Coronary Heart Disease and Generalization of Standardized Secondary Prevention in Chinese Coronary Heart Disease Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00745628
Acronym
CCS-CHD
Enrollment
10000
Registered
2008-09-03
Start date
2008-05-31
Completion date
2010-12-31
Last updated
2008-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Diseases

Keywords

coronary heart disease, secondary prevention

Brief summary

Construction of coronary heart disease cohort of more than 10000 patients in China. Investigation on current situation of secondary prevention of CHD will be carried out and the effect of physician training and patient education will be evaluated.

Detailed description

More than 40 hospitals of 16 provinces will enroll patients for this study. The study will include patients with diagnosed coronary heart disease. Investigators and all the physicians who will involve in daily care of CHD patients will have a brief training on guideline of secondary prevention in CHD and take a test on that. Questionnaires are used to evaluate patient's cognition of their diseases and knowledge on coronary heart disease. Patient education will be carried out during a 2 years follow up of all the patient enrolled before they are required to fill out another questionnaire. Physicians will also take a second test on secondary prevention of CHD at that time. Patients will take blood lipids and glucose test according to their physician's requirement.The effect of physician training and patient education will be evaluated by comparing the results of questionnaires and tests at the beginning of the study and in the end of the 2 years follow up.

Interventions

None listed

Sponsors

Ministry of Science and Technology of the People´s Republic of China
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diagnosed coronary heart disease * Confirmed by coronary angiography; * Diagnosed myocardial infarction; * Typical symptom of ischemic chest pain with positive stress test; * Willing to sign an inform consent.

Exclusion criteria

* Patients won't sign an inform consent or will not comply with the follow up.

Countries

China

Contacts

Primary ContactTao Hong, MD
dr_hongtao@163.com86-10-66551122

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026